Bonelli J, Rameis H, Waginger H
Int J Clin Pharmacol Ther Toxicol. 1981 Mar;19(3):93-5.
Two groups of seven healthy volunteers were treated for 9 days with either 0.3 mg beta-methyldigoxin or 0.4 mg beta-acetyldigoxin daily, applied orally. On the 10th day, digoxin concentrations in plasma and cerebrospinal fluid (CSF) were determined by radioimmunoassay. After therapy with beta-methyldigoxin the plasma/CSF digoxin concentration ratio was 3.7:1; after therapy with beta-acetyldigoxin it was 3.2:1. There was no significant difference in the plasma/CSF digoxin concentration ratio after 9 days of treatment with equipotent doses of beta-methyldigoxin and beta-acetyldigoxin.
两组七名健康志愿者分别每日口服0.3毫克β-甲基地高辛或0.4毫克β-乙酰地高辛,持续治疗9天。在第10天,通过放射免疫分析法测定血浆和脑脊液(CSF)中的地高辛浓度。用β-甲基地高辛治疗后,血浆/脑脊液地高辛浓度比为3.7:1;用β-乙酰地高辛治疗后,该比例为3.2:1。用等效剂量的β-甲基地高辛和β-乙酰地高辛治疗9天后,血浆/脑脊液地高辛浓度比无显著差异。